A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
Status:
Not yet recruiting
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
This study is a multicenter, open phase I clinical study of dose escalation and dose
extension of HRS7415 in subjects with advanced malignant tumors. To evaluate the safety,
tolerability, pharmacokinetics and efficacy of HRS7415 tablets.